European Journal of Endocrinology

Article	Citations
Mineralocorticoid receptor antagonists for primary aldosteronism—appropriate or not?	477
Normative cut-offs for polycystic ovary syndrome diagnostic features in adolescents using cluster analysis	275
EndoCompass project: research roadmap for growth disorders	170
18-year change in serum intact fibroblast growth factor 23 from midlife to late life and risk of mortality: the ARIC Study	128
OC45 - IL-1β/CXCL12 axis drives the crosstalk between PanNET cells and adipocytes	126
OC40 - Aldosterone/cortisol ratio as a new marker for diagnosing mild autonomous cortisol secretion (MACS). Investigating the effects of mild hypercortisolism on the renin-angiotensin-aldosterone syst	118
P12 - Morning spot urine iodine-to-creatinine ratio as a surrogate for 24-hour iodine excretion in adult non-pregnant women	94
Prevalence and determinants of dyslipidemia in 2338 Dutch childhood cancer survivors: a DCCS-LATER 2 study	87
Synchronous bilateral adrenalectomy for ACTH-independent Cushing's syndrome in children: multidisciplinary management	74
Extensive expertise in endocrinology: adrenal crisis in assisted reproduction and pregnancy	73
Challenges estimating the effects of testosterone on health outcomes in transgender men: immortal time bias and other methodological concerns	73
EndoCompass project: the place of endocrinology in European research funding—an analysis of Horizon 2020	67
Serum diiodotyrosine – a biomarker to differentiate destructive thyroiditis from Graves’ disease	63
When selection becomes selection bias	61
Compression of the optic chiasm is associated with reduced photoentrainment of the central biological clock	60
Accurate diagnosis of congenital adrenal hyperplasia due to CYP21A2 variants requires promoter analysis	55
Prevalence of drugs used for chronic conditions after diagnosis of thyroid cancer: a register-based cohort study	53
Autophagy markers are decreased in bone of osteoporotic patients: a monocentric comparative study	51
A larger brown fat volume and lower radiodensity are related to a greater cardiometabolic risk, especially in young men	51
Primary adrenal insufficiency in patients with CPOX gene mutations	49
Differential effects of sodium–glucose cotransporter 2 inhibitors on cardiovascular and renal outcomes according to renal function: a dose–response meta-analysis involving 10 randomized clinical trial	47
Two-year clinical outcomes of microwave ablation for benign thyroid nodules: results from a multicenter study	46
Biallelic POC1A variants cause syndromic severe insulin resistance with muscle cramps	45
Ectopic lipid deposition and insulin resistance in patients with GH disorders before and after treatment	44
Metformin treatment is associated with reduced risk of hypoglycaemia, major adverse cardiovascular events, and all-cause mortality in patients with post-pancreatitis diabetes mellitus: a nationwide co	44

Factors predicting normalization of reproductive hormones after cessation of anabolic-androgenic steroids in men: a single center retrospective study	43
Impact of sex hormones on pheochromocytomas, paragangliomas, and gastroenteropancreatic neuroendocrine tumors	41
Loss of function of FIGNL1, a DNA damage response gene, causes human ovarian dysgenesis	39
Prevalence of adrenal rest tumors and course of gonadal dysfunction in a clinical sample of men with congenital adrenal hyperplasia: a longitudinal analysis over 10 years	39
Defining benchmark outcomes for transsphenoidal surgery of pituitary adenomas: a multicenter analysis	37
Real-world experience with 11C-methionine positron emission tomography in the management of acromegaly	36
European clinical guidance for the management of adrenal and extra-adrenal paraganglioma in children and adolescents: a consensus by the EXPeRT group	35
Cardiovascular risk in Danish transgender persons: a matched historical cohort study	35
Radiotherapy in aggressive or dopamine agonists resistant prolactinomas; is it still worthwhile?	35
AMH as part of the diagnostic PCOS workup in large epidemiological studies	34
Soluble alpha klotho—impact of biological variables and reference intervals for adults	34
Primary hyperaldosteronism induces congruent alterations of sodium homeostasis in different skeletal muscles: a 23Na-MRI study	32
European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and therapy of glucocorticoid-induced adrenal insufficiency	32
OC05 - The clinical risk scores for Cushing’s Syndrome overlap with the phenotype of partial lipodystrophies	32
Parathyroid hormone in situ measurement in patients with hyperparathyroidism: single-centre experience of 179 patients	31
Leflutrozole in male obesity-associated hypogonadotropic hypogonadism: Ph 2b double-blind randomised controlled trial	31
Bone strain index for fracture risk assessment in older men—the prospective STRAMBO study	31
Preoperative calcitonin testing improves the diagnosis of medullary thyroid carcinoma in female and male patients	31
Digital quantification of somatostatin receptor subtypes 2 and 5 in growth hormone–secreting pituitary tumors	30
Transcriptional comparison of testicular adrenal rest tumors with fetal and adult tissues	29
Metabolic health during a randomized controlled lifestyle intervention in women with PCOS	29
Novel GLCCI1-BRAF fusion drives kinase signaling in a case of pheochromocytomatosis	28
Response to the letter: Health outcomes of testosterone therapy in transgender men: methodological issues warrant caution	27
Correction to: Recombinant human parathyroid hormone (1–84) is effective in CASR-associated hypoparathyroidism	27
Thyroid strain in pregnancy: a nationwide study of iodine nutrition and thyroglobulin among Faroese pregnant women	27
Physiological declines in sex steroid exposure in relation to changes in body composition in healthy men—a prospective cohort study	26
Higher peak height velocity in early maturing girls depends on insulin rather than fat mass or IGF-I	26
A simple fragility fracture risk score for type 2 diabetes patients: a derivation, validation, comparison, and risk stratification study	26
Vaginal bleeding in women with ovarian neuroendocrine tumor metastases should not be overlooked	26
P32 - Transient 18F-FDG PET/CT uptake of contralateral adrenal gland in patient under mitotane for R0 corticosurrenaloma	25
No need of glucocorticoid dose adjustment in patients with adrenal insufficiency before COVID-19 vaccine	25
Using electronic health record data for clinical research: a quick guide	25
EndoCompass project: environmental endocrinology	25
P44 - A strange case of primary amenorrhea	25
Influence of smoking on cardiometabolic profile and surgical outcomes in patients with primary aldosteronism: a cohort study	25
Response to the letter from Massimo Giusti	25
Urea-stimulated copeptin: a novel diagnostic approach in polyuria polydipsia syndrome	24
P48 - Drug response profiling of adrenocortical carcinoma in vitro models reveals differential sensitivity to cisplatin and etoposide	24
Familial central precocious puberty due to DLK1 deficiency: novel genetic findings and relevance of serum DLK1 levels	24
The clinical and biochemical significance of 11-oxygenated androgens in human health and disease	24
Long-term pituitary function and functional and patient-reported outcomes in severe acquired brain injury	23
Serum and hair steroid profiles and their associations with body composition in adolescence	23
Epidemiological and clinical data from the European Lipodystrophy Registry	23
C-peptide level concomitant with hypoglycemia gives better performances than insulin for the diagnosis of endogenous hyperinsulinism: a single-center study of 159 fasting trials	22
Correction to: Long-term effects of primary hyperparathyroidism and parathyroidectomy on kidney function	22
Healthcare cost and survival in patients with non-functioning pituitary adenoma	22
The metabolic phenotype of patients with primary aldosteronism: impact of subtype and sex – a multicenter-study of 3566 Caucasian and Asian subjects	22
Predictors of treatment response in lymphogenic metastasized papillary thyroid cancer: a histopathological study	22
Early puberty suppression and gender-affirming hormones do not alter final height in transgender adolescents	22
OC25 - Exploring miR-200 family expression in obesity	21

Growth hormone treatment adjusted for growth hormone sensitivity in idiopathic short stature	21
Diagnostic strategies for central adrenal insufficiency in clinical practice: authors’ response	21
Uniparental disomy leads to a novel cause of MC2R-related familial glucocorticoid deficiency type 1	21
P33 - A rare case of thyroblastoma with atypical somatic mutations	21
Risk of depression in patients with acromegaly in Korea (2006-2016): a nationwide population-based study	21
EXTENSIVE EXPERTISE IN ENDOCRINOLOGY: My quarter century quest to understand the paradox of marrow adiposity	21
EndoCompass project: research roadmap for diabetes, obesity, and metabolism	20
Long-term antitumour effects of pasireotide in acromegaly	20
Impact of antiresorptive agents on mortality risk in postmenopausal women with osteoporosis: insights from a nationwide cohort study	20
Paraprotein-induced spurious hypercalcaemia: diagnostic pitfalls in two cases	20
Severe symptomatic hyponatremia in Europe: insights into current clinical practice	20
A novel somatostatin receptor ligand for human ACTH – and GH –secreting pituitary adenomas	19
Novel Glial Cells Missing-2 (GCM2) variants in parathyroid disorders	19
Cabergoline targets multiple pathways to inhibit PRL secretion and increases stromal fibrosis	19
Medical treatment in acromegaly: a network meta-analysis	19
Metaphyseal band fractures in pediatric patients treated with denosumab	19
Prevalence, risk factors, and optimal way to determine overweight, obesity, and morbid obesity in the first Dutch cohort of 2338 long-term survivors of childhood cancer: a DCCSS-LATER study	18
Body image concerns in women with polycystic ovary syndrome: a systematic review and meta-analysis	18
Pituitary apoplexy in SARS-CoV-2 infected is not necessarily related to the virus	18
Denosumab withdrawal increases vertebral fracture and mortality risk compared with zoledronate	18
Retraction of: Comparison of finasteride versus flutamide in the treatment of hirsutism	17
Circulating miR-20a-5p as a biomarker associated with cabergoline responsiveness in patients with hyperprolactinemia and pituitary adenomas	17
Quality of life in patients with overt hypothyroidism: a systematic review	17
Role of genetics in the age-related testosterone decline in men: a UK Biobank study	17
Prognostic value of dysnatremia for survival in neuroendocrine neoplasm patients	17
OC43 - Radiogenomics pilot study in adrenocortical carcinoma: assessing the relationship between genetic background and computerized tomography texture	17
Increased cardiovascular morbidity and reduced life expectancy in a large Italian cohort of patients with resistance to thyroid hormone β (RTHβ)	17
The not-so-shortcomings of seated saline suppression testing in primary aldosteronism	16
HLA investigation in ICI-induced T1D and isolated ACTH deficiency including meta-analysis	16
Gonadal tumor development in 46,XX disorders of gonadal development	16
Primary hyperparathyroidism induces erythropoietin resistance through fibroblast growth factor 23	16
Concomitant gut dysbiosis and defective gut barrier serve as the bridges between hypercortisolism and chronic systemic inflammation in Cushing’s disease	16
Mild Hyponatremia in Hospitalized Patients: Revisiting Bone Turnover and Clinical Implications	16
Agouti-related peptide: a promising prognostic biomarker in adrenocortical carcinoma. Results from a large single-centre cross-sectional analysis	16
Saline suppression testing-induced hypocalcemia and implications for clinical interpretations	16
Uterine changes in transgender men receiving testosterone therapy	16
Acromegaly and the risk of cancer: a nationwide population-based cohort study in Korea	16
Sex-specific effect of maternal thyroid peroxidase antibody exposure during pregnancy on 5- to 6-year-old children's cardiometabolic risk score: the Ma'anshan birth cohort study	15
OC54 - Role of steroid hormone-binding proteins on the bioactivity of 11-oxygenated androgens	15
NF1gene inactivation acts as a tumor driver inRET/RAS-negative medullary thyroid carcinomas	15
Long-term outcomes in patients with congenital adrenal hyperplasia treated with hydrocortisone modified-release hard capsules	15
PRAP study—partial versus radical adrenalectomy in hereditary pheochromocytomas	15
Hyperandrogenaemia, polycystic ovary syndrome, and physical fitness in women—a Northern Finland birth cohort study	15
OC38 - Prevalence and predictors of testicular adrenal rest tumors in adults with congenital adrenal hyperplasia	15
Transcriptomic classification of prolactinomas and somatotropinomas identifies subtypes with variable resistance to treatment	15
Pituitary apoplexy and SARS-CoV-2 infection: we need to look beyond the acute phase	15
Correction to: Somapacitan in children born small for gestational age: a multi-centre, open-label, controlled phase 2 study	15
OC55 - The role of obstructive sleep apnea syndrome and continuous positive airways pressure therapy in the functional hypogonadism of male patients with severe obesity	15
Identifying factors associated with subsequent diagnosis of adrenal adenoma: a population-based historical case–control study	15
Impact of GH administration on skeletal endpoints in adults with overweight/obesity	15
Polycystic ovary syndrome presents as a multimorbid condition by age 50: birth cohort linkage to national register data	14
In-depth proteomic signature of parathyroid carcinoma	14
Patients' perspective on the medical pathway from first symptoms to diagnosis in genetic lipodystrophy	14
EndoCompass project: research roadmap for calcium and bone endocrinology	14
Integrative clinical, hormonal, and molecular data associate with invasiveness in acromegaly: REMAH study	14
Spleen function is reduced in individuals with NR5A1 variants with or without a difference of sex development: a cross-sectional study	14
Sexual dimorphism in benign adrenocortical tumours	14
Obesity risk is associated with brain glucose uptake and insulin resistance	14
Effect of hyponatremia normalization on osteoblast function in patients with SIAD	14
Non-suppression of renin by renal cysts in a subset of patients with primary aldosteronism—a prospective observational single center study	14
Hypoxia signaling pathway activation in osteoblasts suppresses osteocalcin production but does not alter male fertility in mice	14
Clinical and genetic heterogeneity of HNF4A/HNF1A mutations in a multicentre paediatric cohort with hyperinsulinaemic hypoglycaemia	13
Serum 25-hydroxy vitamin D and the risk of low muscle mass in young and middle-aged Korean adults	13
Bone-active drugs in premenopausal women with breast cancer under hormone-deprivation therapies	13
Target therapy forBRAFmutated anaplastic thyroid cancer: a clinical and molecular study	13
How to manage Cushing's disease after failed primary pituitary surgery	13
ACTH-independent production of 11-oxygenated androgens and glucocorticoids in an adrenocortical adenoma	13
Therapeutic management of congenital forms of endocrine hypertension	13
Subgroup analyses in clinical research: too tempting?	13
Extensive expertise in endocrinology: advances in the management of glucocorticoid-induced osteoporosis	13
Improving diagnosis in primary aldosteronism using HISTALDO and nodule size metrics	13
KCNJ5 mutations in familial and non-familial primary aldosteronism	13
Regulation of insulin expression and release in gene and cell therapy of insulin-deficient diabetes	13
Increased systemic and adipose 11β-HSD1 activity in idiopathic intracranial hypertension	13
Randomized controlled trial of Tesomet for weight loss in hypothalamic obesity	13
Adrenal wash-out CT: moderate diagnostic value in distinguishing benign from malignant adrenal masses	13
Sex steroids and androgen biomarkers in the healthy man study: within-person variability and impact of fasting	13
P36 - Adavosertib-mediated wee1 inhibition as a strategy to overcome cisplatin resistance in non-seminoma testicular cancer: insights from preclinical models	12
Prevalence and clinical correlations of SF3B1 variants in lactotroph tumours	12
EJE Prize 2023: genes on steroids—genomic control of hepatic metabolism by the glucocorticoid receptor	12

Does exercise beneficially affect sex hormones when added to hypo-caloric diets in adults with overweight or obesity? A systematic review and meta-analysis of controlled clinical trials	12
OC42 - Ectopic Cushing's syndrome (ECS) - a diagnostic challenge. Differences between ECS and Cushing's disease (CD) - European Cushing's syndrome registry, ERCUSYN, Kraków	12
Impact of remission status in endogenous Cushing's syndrome on cancer incidence	12
The glucagon receptor antagonist LY2409021 has no effect on postprandial glucose in type 2 diabetes	12
OC20 - Effectiveness of bisphosphonates and denosumab on risk of vertebral fractures in prostate cancer patients under androgen-deprivation therapies: a real-world prospective study	12
Autoimmune thyroid disease and thyroid function test fluctuations in patients with resistance to thyroid hormone	12
Altered biomarkers for cardiovascular disease and inflammation in autoimmune Addison's disease – a cross-sectional study	12
Copeptin improves prediction of treatment response in children with monosymptomatic nocturnal enuresis	12
IGF-I assay methods and biologic variability: evaluation of acromegaly treatment response	11
Association of menopausal hormone therapy with risk of cardiovascular disease in Korean women	11
Testicular volume in 268 children and adolescents followed-up for childhood obesity—a retrospective cross-sectional study	11
Low-grade inflammation during the glucocorticoid withdrawal phase in patients with Cushing's syndrome	11
The American Thyroid Association risk classification of papillary thyroid cancer according to presurgery cytology	11
Dose–exposure–IGF-I response of once-weekly somapacitan in adults with GH deficiency	11
Association between premature ovarian insufficiency and biological aging	11
Clinical features of anti-pituitary-specific transcription factor-1 (PIT-1) hypophysitis: a new aspect of paraneoplastic autoimmune condition	11
Clinical and imaging presentations are associated with function in incidental adrenocortical adenomas: a retrospective cohort study	11
Impact of exenatide on weight loss and eating behavior in adults with craniopharyngioma-related obesity: the CRANIOEXE randomized placebo-controlled trial	11
Insulitis in human type 1 diabetes: lessons from an enigmatic lesion	11
Biomarkers for subtype stratification in primary aldosteronism: current and future perspectives	11
Adrenal–adipose tissue crosstalk in health and disease	11
European Society of Endocrinology clinical practice guideline for evaluation and management of menopause and the perimenopause	11
Correction to: Copeptin improves prediction of treatment response in children with monosymptomatic nocturnal enuresis	11
Comorbidities in mild autonomous cortisol secretion and the effect of treatment: systematic review and meta-analysis	11
Bariatric surgery promotes recruitment of brown fat linked to alterations in the gut microbiota	11
Gonadotropic status in adult women with pituitary stalk interruption syndrome	11
Estimated global prevalence of genetic carriers of hereditary pheochromocytoma-paraganglioma syndrome in a large multiethnic genomic database	11
Recombinant growth hormone improves growth and adult height in patients with maternal inactivating GNAS mutations	10
Femora of women with premature ovarian insufficiency exhibit reduced strength and misalignment with the transmitted vertical forces from the upper body	10
Serum steroid metabolome dynamics in infancy: a longitudinal cohort study of healthy infants	10
Single-cell RNA sequencing in silent corticotroph tumors confirms impaired POMC processing and provides new insights into their invasive behavior	10
Exenatide for diagnosing endogenous hyperinsulinemic hypoglycemia: a randomized placebo-controlled, double-blind, cross-over proof-of-principle study	10
Modified-release hydrocortisone is associated with lower plasma renin activity in patients with salt-wasting congenital adrenal hyperplasia	10
Author reply to comments by Wang et al. regarding “Musculoskeletal disease in acromegaly—a population-based registry study”	10
Extensive expertise in endocrinology: glucose-dependent insulinotropic peptide–dependent Cushing's syndrome	10
Diurnal cortisol features with cardiovascular disease in hypertensive patients: a cohort study	10
OC11 - Calcitonin levels in patients with chronic kidney disease: a retrospective monocenter observational study	10
GLOBAL ENDOCRINOLOGY: Geographical variation in the profile of RET variants in patients with medullary thyroid cancer: a comprehensive review	10
Fetal growth restriction inhibits childhood growth despite catch-up in discordant identical twins: an observational cohort study	10
Normal thyroid volume and goitre diagnosis on ultrasonography is population-sensitive	10
Differential cardiovascular risks of menopausal hormone therapy: insights from a Korean cohort	10
Response to commentary: strengthening endocrinology training: integrating nonclinical competencies, patient, and trainee perspectives for better implementation strategies	10
Circulating cell-free DNA-based biomarkers for prognostication and disease monitoring in adrenocortical carcinoma	10
SGA-born adults with postnatal catch-up have a persistently unfavourable metabolic health profile and increased adiposity at age 32 years	10
P21 - Exploring microvascular changes in the bulbar conjunctiva of patients with type 1 diabetes	10
High prevalence of subnormal testosterone in obese adolescent males: reversal with bariatric surgery	10
OC03 - [18F] Fluorethyltyrosine positron emission tomography in corticotroph pituitary adenomas	10
OC44 - Therapeutic potential of adavosertib (AZD1775), a WEE1 kinase inhibitor, in advanced adrenocortical carcinoma: focus on molecular changes	10
Characterization of dominant-negative growth hormone receptor variants reveals a potential therapeutic target for short stature	10
Recovery of adrenal function after stopping mitotane in patients with adrenocortical carcinoma	10
Real-world outcomes of finerenone in primary aldosteronism	9
OC15 - A novel synergistic approach: indocyanine green-based photodynamic therapy combined with docetaxel for papillary thyroid cancer treatment	9
Gene expression profiling of subcutaneous adipose tissue reveals new biomarkers in acromegaly	9
Use of total calcium in hypoparathyroidism: A pragmatic approach but with limitations	9
Locally advanced pheochromocytoma/paraganglioma exhibit high metastatic recurrence and disease specific mortality rates: long-term follow-up of 283 patients	9
The glucagon receptor antagonist LY2409021 does not affect gastrointestinal-mediated glucose disposal or the incretin effect in individuals with and without type 2 diabetes	9
Real-life clinical impact of a five-tiered classification of pituitary tumors	9
Rare ZMPSTE24 variants increase risk of hypertriglyceridemia and metabolic syndrome	9
Health-related quality of life in a cohort of 1070 patients with hypoparathyroidism	9
An impressive response with larotrectinib in a patient with a papillary thyroid carcinoma harboring an SQSTM1-NTRK1 fusion	9
Glucose pattern in children with classical congenital adrenal hyperplasia: evidence from continuous glucose monitoring	9
Retraction of: Conventional steroids vs. dual-release hydrocortisone on metabolic, cardiovascular, and bone outcomes in adrenal insufficiency: a 10-year study	9
Accelerated MEN2A in homozygous RET carriers in the context of consanguinity	9
Pancreas transplantation today: quo vadis?	9
Congenital hypogonadotropic hypogonadism in a patient with a de novoPOGZmutation	9
Inhaled glucocorticoid-induced metabolome changes in asthma	9
Assessing the utility of aldosterone suppression testing for primary aldosteronism: time to move forward	9
Letter to the editor: sociodemographic, lifestyle, and medical factors associated with calculated free testosterone concentrations in men: individual participant data meta-analyses	9
The socioeconomic burden of acromegaly	9
Ketone supplementation acutely lowers androgen and glucose levels in women with polycystic ovary syndrome: a randomized clinical trial	9
P18 - A new LC-MS/MS method for the determination of serum cortisol, cortisone, and dexamethasone: utility in the interpretation of the low-dose dexamethasone suppression test	9
Effects of metyrapone in patients with mild hypercortisolism	9
Revised European Society of Endocrinology Clinical Practice Guideline: Treatment of Chronic Hypoparathyroidism in Adults	9
Cushing's syndrome in the elderly: data from the European Registry on Cushing's syndrome	9
Efficacy and safety of medical treatment of primary aldosteronism: a real-world data study in Spain	9
The power of sample size calculations	9
Randomized double-blind placebo-controlled trial on levothyroxine and liothyronine combination therapy in totally thyroidectomized subjects: the LEVOLIO study	9
Functional evaluation of a novel nonsense variant of the calcium-sensing receptor gene leading to hypocalcemia	9
Caveolar dysfunction and lipodystrophies	9
OC49 - Phenotypic transformation of a non-functioning pancreatic neuroendocrine tumour to a hormonally active insulinoma	8
P37 - Correlation between seminal testosterone and cortisol and semen parameters in normozoospermic and teratozoospermic men	8
Natural history of nonfunctioning pituitary microadenomas: a systematic review and individual participant data meta-analysis	8
The interplay of thyroid hormones and the immune system – where we stand and why we need to know about it	8
Survival probabilities in patients with ectopic Cushing's syndrome—a systematic review and a single-arm meta-analysis	8
P19 - Reevaluation of diastolic dysfunction in obese individuals: can indexed left atrial enlargement and reduced atrial strain redefine diastolic dysfunction?	8
Efficacy of cabergoline in non-irradiated patients with acromegaly: a multi-centre cohort study	8
Self-management and hospitalization in 615 Swedish patients with Addison's disease during the coronavirus disease 2019 pandemic: a retrospective study	8
The genetic etiology is a relevant cause of central precocious puberty	8
Response to the letter by Schmitt et al.	8
OC57 - A multinational observational study on the clinical characteristics and treatments offered to women with polycystic ovary syndrome (PCOS)-related skin conditions presenting to specialist clinic	8
A global real-world study assessing total time to adrenalectomy in primary aldosteronism	8
Sex differences in MEN 2A penetrance and expression according to parental inheritance	8
Addition of testosterone to endocrine care for transgender women: a dose-finding and feasibility trial	8
Long-term mortality and cardiovascular events in patients with unilateral primary aldosteronism after targeted treatments	8
Investigating effectiveness of gender-affirming care: study design considerations	8